Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry
- Sprache
-
Englisch
- Identifier
-
1122827660
Thema
-; Kardiovaskuläre Krankheit
Beteiligte Personen und Organisationen
Gitt, Anselm K.
Bramlage, Peter
Potthoff, Sebastian A.
Baumgart, Peter
Mahfoud, Felix
Buhck, Hartmut
Ehmen, Martina
Ouarrak, Taoufik
Senges, Jochen
Schmieder, Roland E.
Bramlage, Peter
Potthoff, Sebastian A.
Baumgart, Peter
Mahfoud, Felix
Buhck, Hartmut
Ehmen, Martina
Ouarrak, Taoufik
Senges, Jochen
Schmieder, Roland E.
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:58 MEZ
Beteiligte
- Gitt, Anselm K.
- Bramlage, Peter
- Potthoff, Sebastian A.
- Baumgart, Peter
- Mahfoud, Felix
- Buhck, Hartmut
- Ehmen, Martina
- Ouarrak, Taoufik
- Senges, Jochen
- Schmieder, Roland E.
Ähnliche Objekte (12)
EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
Review of direct renin inhibition by aliskiren
Wilder's principle: pre-treatment value determines post-treatment response
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design
Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
Vitamin D receptor regulates TNF-mediated arthritis
Change in Augmentation Index during NOS Inhibition, an Index of Basal NO Production, Is an Independent Determinant of Large-Artery Function
Wirkung des Kalziumantagonisten Manidipin auf den zentralen Blutdruck bei Patienten mit essentieller Hypertonie in Monotherapie und in Kombination mit dem ACE-Hemmer Delapril
EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
Review of direct renin inhibition by aliskiren
Wilder's principle: pre-treatment value determines post-treatment response
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design
Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
Vitamin D receptor regulates TNF-mediated arthritis
Change in Augmentation Index during NOS Inhibition, an Index of Basal NO Production, Is an Independent Determinant of Large-Artery Function
Wirkung des Kalziumantagonisten Manidipin auf den zentralen Blutdruck bei Patienten mit essentieller Hypertonie in Monotherapie und in Kombination mit dem ACE-Hemmer Delapril
EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
Review of direct renin inhibition by aliskiren
Wilder's principle: pre-treatment value determines post-treatment response
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design
Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
Vitamin D receptor regulates TNF-mediated arthritis
Change in Augmentation Index during NOS Inhibition, an Index of Basal NO Production, Is an Independent Determinant of Large-Artery Function